LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 161 filers reported holding LOXO ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is 1.63 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $2,382,000 | -35.8% | 17,008 | -21.7% | 0.00% | -33.3% |
Q3 2018 | $3,710,000 | -20.2% | 21,719 | -19.0% | 0.00% | -25.0% |
Q2 2018 | $4,651,000 | +71.7% | 26,809 | +14.2% | 0.00% | +33.3% |
Q1 2018 | $2,709,000 | +127.5% | 23,479 | +66.0% | 0.00% | +200.0% |
Q4 2017 | $1,191,000 | -50.9% | 14,144 | -46.3% | 0.00% | -66.7% |
Q3 2017 | $2,426,000 | -6.5% | 26,337 | -18.7% | 0.00% | 0.0% |
Q2 2017 | $2,596,000 | +63.7% | 32,379 | -14.1% | 0.00% | +50.0% |
Q1 2017 | $1,586,000 | +316.3% | 37,679 | +129.0% | 0.00% | +100.0% |
Q2 2016 | $381,000 | +5.2% | 16,457 | +24.3% | 0.00% | 0.0% |
Q1 2016 | $362,000 | – | 13,235 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 2,038,920 | $285,592,000 | 80.87% |
DAFNA Capital Management LLC | 181,675 | $25,447,000 | 12.65% |
Opaleye Management Inc. | 175,000 | $24,512,000 | 9.15% |
Casdin Capital, LLC | 360,000 | $50,425,000 | 8.63% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 21,775 | $3,050,000 | 3.58% |
Avoro Capital Advisors LLC | 325,000 | $45,523,000 | 2.72% |
AWM Investment Company, Inc. | 70,000 | $9,805,000 | 2.13% |
Opus Point Partners Management, LLC | 6,210 | $870,000 | 1.92% |
Eventide Asset Management | 274,000 | $38,379,000 | 1.70% |
Aquilo Capital Management, LLC | 24,750 | $3,467,000 | 1.68% |